Here we address, at first glance, the confusing and paradoxical aspect of the model, namely, that treatment of rats with the antiangiogenic vascular endothelial growth factor (VEGF) receptor 1 and 2 ...

Endothelial dysfunction markers were linked to future disease activity and complications in lcSSc.

Uncontrolled proliferation of endothelial cells in small pulmonary arteries is a key feature in the pathogenesis of pulmonary hypertension. Now it has been shown that small RNA fragments ...

Pulmonary arterial hypertension is a rare form of pulmonary hypertension that poses diagnostic challenges and often comes with a delayed diagnosis.

However, they took Hopkins' symptoms seriously, even when she pushed them on an initial diagnosis of a lung disease diagnosis ...

Patients at particular risk for postoperative pulmonary hypertension can be identified preoperatively based on their cardiac disease and can be grouped into four broad categories based on the ...

A relatively new therapy used to treat pulmonary arterial hypertension in those with mild to moderate disease was found to be effective at preventing death in those with more advanced disease ...

A protein called BMPER found at low levels in models has emerged as a PAH treatment target as it may ease disease progression ...

Those endothelial cells and finding ways to fix them when they become dysfunction is a critical focus of this new five-year grant.

Pulmonary hypertension is a quickly advancing disease. Learn about how this form of high blood pressure affects life expectancy, its treatments, and more.